J&J started testing the vaccine in adults in a 60,000-volunteer Phase III study in late September. It had to pause the trial earlier this month because of a serious medical event in one participant. The study resumed last week.
from Hindustan Times - world https://ift.tt/2JcF2hB
No comments:
Post a Comment